Sphera Funds Management Ltd 13F annual report
Sphera Funds Management Ltd is an investment fund managing more than $613 billion ran by Oshrat Levi. There are currently 109 companies in Levi’s portfolio. The largest investments include BridgeBio Pharma Inc and Sanofi, together worth $44.9 billion.
$613 billion Assets Under Management (AUM)
As of 7th August 2024, Sphera Funds Management Ltd’s top holding is 910,070 shares of BridgeBio Pharma Inc currently worth over $23.1 billion and making up 3.8% of the portfolio value.
Relative to the number of outstanding shares of BridgeBio Pharma Inc, Sphera Funds Management Ltd owns more than approximately 0.1% of the company.
In addition, the fund holds 449,515 shares of Sanofi worth $21.8 billion, whose value grew 15.8% in the past six months.
The third-largest holding is Cytokinetics Inc worth $20.9 billion and the next is Amazon.com worth $19.6 billion, with 101,432 shares owned.
Currently, Sphera Funds Management Ltd's portfolio is worth at least $613 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Sphera Funds Management Ltd
The Sphera Funds Management Ltd office and employees reside in Tel Aviv, Israel. According to the last 13-F report filed with the SEC, Oshrat Levi serves as the Chief Financial Officer at Sphera Funds Management Ltd.
Recent trades
In the most recent 13F filing, Sphera Funds Management Ltd revealed that it had opened a new position in
Skye Bioscience Inc and bought 1,298,312 shares worth $10.4 billion.
The investment fund also strengthened its position in BridgeBio Pharma Inc by buying
324,114 additional shares.
This makes their stake in BridgeBio Pharma Inc total 910,070 shares worth $23.1 billion.
BridgeBio Pharma Inc dropped 24.2% in the past year.
On the other hand, there are companies that Sphera Funds Management Ltd is getting rid of from its portfolio.
Sphera Funds Management Ltd closed its position in Perspective Therapeutics Inc on 14th August 2024.
It sold the previously owned 12,443,621 shares for $14.8 billion.
Oshrat Levi also disclosed a decreased stake in Sanofi by 0.1%.
This leaves the value of the investment at $21.8 billion and 449,515 shares.
One of the average hedge funds
The two most similar investment funds to Sphera Funds Management Ltd are Cornercap Investment Counsel Inc and Inscription Capital. They manage $614 billion and $613 billion respectively.
Oshrat Levi investment strategy
Sphera Funds Management Ltd’s portfolio is diversified across 6 sectors.
Currently, their heaviest sector is Health Care — making up 42.3% of
the total portfolio value.
The fund focuses on investments in the United States as
48.6% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
24% of the total holdings value.
On the other hand, small-cap stocks make up only 8.3% of the portfolio.
The average market cap of the portfolio companies is close to $107 billion.
The complete list of Sphera Funds Management Ltd trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| BridgeBio Pharma Inc |
55.31%
910,070
|
$23,052,073,000 | 3.76% |
| Sanofi |
10.01%
449,515
|
$21,810,468,000 | 3.56% |
| Cytokinetics Inc |
36.66%
384,924
|
$20,855,182,000 | 3.40% |
| Amazon.com Inc. |
86.35%
101,432
|
$19,601,734,000 | 3.20% |
| Syndax Pharmaceuticals Inc |
1.12%
822,047
|
$16,876,625,000 | 2.75% |
| Meta Platforms Inc |
31.45%
33,439
|
$16,860,613,000 | 2.75% |
| Astrazeneca plc |
No change
190,060
|
$14,822,779,000 | 2.42% |
| Perspective Therapeutics Inc |
Closed
12,443,621
|
$14,807,909,000 | |
| Microsoft Corporation |
19.53%
32,927
|
$14,716,723,000 | 2.40% |
| NICE Ltd |
5.15%
81,461
|
$14,008,848,000 | 2.28% |
| Sarepta Therapeutics Inc |
50.43%
83,659
|
$13,218,122,000 | 2.16% |
| Apple Inc |
251.43%
61,500
|
$12,953,130,000 | 2.11% |
| Teva Pharmaceutical Inds Ltd |
58.23%
789,416
|
$12,828,010,000 | 2.09% |
| Kura Oncology Inc |
No change
610,826
|
$12,576,907,000 | 2.05% |
| Ultragenyx Pharmaceutical In |
23.18%
293,832
|
$12,076,495,000 | 1.97% |
| Eli Lilly Co |
7.05%
13,190
|
$11,941,962,000 | 1.95% |
| Praxis Precision Medicines I |
60.00%
283,424
|
$11,722,417,000 | 1.91% |
| Celldex Therapeutics Inc. |
11.65%
309,265
|
$11,445,898,000 | 1.87% |
| Novo-nordisk A S |
6.02%
78,080
|
$11,145,139,000 | 1.82% |
| Biogen Inc |
32.89%
47,412
|
$10,991,050,000 | 1.79% |
| Skye Bioscience Inc |
Opened
1,298,312
|
$10,399,479,000 | 1.70% |
| Jasper Therapeutics Inc |
10.10%
454,227
|
$10,310,953,000 | 1.68% |
| Johnson Johnson |
12.53%
69,831
|
$10,206,499,000 | 1.66% |
| Asml Holding N V |
Opened
9,901
|
$10,126,050,000 | 1.65% |
| Fusion Pharmaceuticals Inc. |
Closed
449,041
|
$9,573,554,000 | |
| Merus N.V |
1.14%
147,633
|
$8,735,445,000 | 1.42% |
| Salesforce Inc |
Opened
33,600
|
$8,638,560,000 | 1.41% |
| Immatics N.v |
9.76%
731,111
|
$8,495,510,000 | 1.39% |
| Perspective Therapeutics Inc |
Opened
786,909
|
$7,845,483,000 | 1.28% |
| Pharvaris N V |
2.64%
403,265
|
$7,581,382,000 | 1.24% |
| Merck Co Inc |
42.47%
59,600
|
$7,378,480,000 | 1.20% |
| Rezolute Inc |
71.36%
1,707,999
|
$7,344,396,000 | 1.20% |
| Cybin Inc |
No change
25,581,395
|
$6,932,558,000 | 1.13% |
| Vigil Neuroscience Inc |
2.21%
1,692,166
|
$6,768,664,000 | 1.10% |
| Ionis Pharmaceuticals Inc |
Opened
140,238
|
$6,683,743,000 | 1.09% |
| Inozyme Pharma, Inc. |
6.54%
1,462,724
|
$6,523,749,000 | 1.06% |
| Abbvie Inc |
No change
38,000
|
$6,517,760,000 | 1.06% |
| Nova Ltd |
Closed
35,106
|
$6,227,102,000 | |
| Palo Alto Networks Inc |
Opened
18,000
|
$6,102,180,000 | 1.00% |
| Sentinelone Inc |
48.48%
283,804
|
$5,974,074,000 | 0.97% |
| Tower Semiconductor Ltd. |
16.70%
149,600
|
$5,880,776,000 | 0.96% |
| Applied Matls Inc |
23.11%
24,604
|
$5,806,298,000 | 0.95% |
| Enphase Energy Inc |
20.37%
56,792
|
$5,662,730,000 | 0.92% |
| Novartis AG |
No change
50,000
|
$5,323,000,000 | 0.87% |
| Acadia Pharmaceuticals Inc |
162.03%
327,539
|
$5,322,509,000 | 0.87% |
| Mineralys Therapeutics Inc |
32.79%
442,752
|
$5,180,198,000 | 0.84% |
| Incyte Corp. |
Closed
89,556
|
$5,102,005,000 | |
| 4d Molecular Therapeutics In |
49.56%
242,526
|
$5,090,621,000 | 0.83% |
| Micron Technology Inc. |
Opened
37,000
|
$4,866,610,000 | 0.79% |
| Day One Biopharmaceuticals I |
29.43%
347,627
|
$4,790,300,000 | 0.78% |
| Catalyst Pharmaceuticals Inc |
No change
288,000
|
$4,461,120,000 | 0.73% |
| Rocket Pharmaceuticals Inc |
12.63%
206,933
|
$4,455,267,000 | 0.73% |
| JFrog Ltd |
47.46%
117,881
|
$4,426,432,000 | 0.72% |
| 89bio Inc |
2.07%
526,547
|
$4,217,641,000 | 0.69% |
| Outlook Therapeutics Inc |
0.00%
571,428
|
$4,217,139,000 | 0.69% |
| Wix.com Ltd |
52.39%
25,177
|
$4,004,905,000 | 0.65% |
| Lam Research Corp. |
Opened
3,700
|
$3,939,945,000 | 0.64% |
| Savara Inc |
Opened
962,687
|
$3,879,629,000 | 0.63% |
| GSK Plc |
No change
100,000
|
$3,850,000,000 | 0.63% |
| Qualcomm, Inc. |
25.50%
18,825
|
$3,749,564,000 | 0.61% |
| Eledon Pharmaceuticals, Inc. |
Opened
1,297,021
|
$3,424,135,000 | 0.56% |
| Akero Therapeutics Inc |
11.73%
141,620
|
$3,322,405,000 | 0.54% |
| Shl Telemedicine Ltd |
No change
632,456
|
$3,223,438,000 | 0.53% |
| Applied Therapeutics, Inc. |
8.92%
674,268
|
$3,148,832,000 | 0.51% |
| Intellia Therapeutics Inc |
Opened
139,419
|
$3,120,197,000 | 0.51% |
| Broadcom Inc |
1,834.07%
19,360
|
$3,108,306,000 | 0.51% |
| Analog Devices Inc. |
Opened
13,000
|
$2,967,380,000 | 0.48% |
| PTC Therapeutics Inc |
Opened
94,318
|
$2,884,244,000 | 0.47% |
| Solaredge Technologies Inc |
Closed
40,175
|
$2,851,622,000 | |
| Vistagen Therapeutics Inc. |
No change
808,550
|
$2,813,754,000 | 0.46% |
| Pliant Therapeutics, Inc. |
No change
258,554
|
$2,779,456,000 | 0.45% |
| Alector, Inc. |
8.93%
610,000
|
$2,769,400,000 | 0.45% |
| Enlight Renewable Energy Ltd |
No change
169,280
|
$2,735,565,000 | 0.45% |
| Promis Neurosciences Inc |
1.08%
1,814,213
|
$2,721,320,000 | 0.44% |
| KLA Corp. |
Opened
3,300
|
$2,720,883,000 | 0.44% |
| SpringWorks Therapeutics, Inc. |
No change
70,269
|
$2,647,033,000 | 0.43% |
| Disc Medicine Inc |
18.73%
58,044
|
$2,616,043,000 | 0.43% |
| Cargo Therapeutics Inc |
107.34%
155,506
|
$2,553,409,000 | 0.42% |
| Pfizer Inc. |
No change
90,000
|
$2,518,200,000 | 0.41% |
| NVIDIA Corp |
Opened
20,000
|
$2,470,800,000 | 0.40% |
| Global E Online Ltd |
67.96%
66,884
|
$2,425,883,000 | 0.40% |
| Ventyx Biosciences Inc |
2.01%
1,012,749
|
$2,339,450,000 | 0.38% |
| Taboola.com Ltd |
43.97%
667,384
|
$2,295,801,000 | 0.37% |
| Larimar Therapeutics, Inc. |
Opened
312,469
|
$2,265,400,000 | 0.37% |
| L3Harris Technologies Inc |
Opened
10,000
|
$2,245,800,000 | 0.37% |
| ADC Therapeutics SA |
Opened
685,547
|
$2,166,329,000 | 0.35% |
| Nutrien Ltd |
13.99%
40,730
|
$2,073,564,000 | 0.34% |
| Elastic N.V |
Closed
20,000
|
$2,004,800,000 | |
| Advanced Micro Devices Inc. |
Closed
11,000
|
$1,985,390,000 | |
| Perion Network Ltd. |
Opened
234,609
|
$1,958,985,000 | 0.32% |
| Alpine Immune Sciences Inc |
Closed
44,841
|
$1,777,497,000 | |
| Kyverna Therapeutics Inc |
Opened
236,029
|
$1,770,218,000 | 0.29% |
| Five9 Inc |
Closed
27,500
|
$1,708,025,000 | |
| Alumis Inc |
Opened
125,000
|
$1,662,500,000 | 0.27% |
| Eliem Therapeutics Inc |
Opened
215,179
|
$1,529,923,000 | 0.25% |
| Werewolf Therapeutics Inc |
No change
626,810
|
$1,529,416,000 | 0.25% |
| Astria Therapeutics Inc |
44.31%
162,842
|
$1,481,862,000 | 0.24% |
| Vir Biotechnology Inc |
Opened
162,051
|
$1,442,254,000 | 0.24% |
| Monte Rosa Therapeutics Inc |
Opened
375,000
|
$1,402,500,000 | 0.23% |
| Marvell Technology Inc |
Opened
20,000
|
$1,398,000,000 | 0.23% |
| Corbus Pharmaceuticals Hldgs |
Closed
35,000
|
$1,373,400,000 | |
| Geron Corp. |
Closed
384,356
|
$1,268,375,000 | |
| Upwork Inc |
No change
117,000
|
$1,257,750,000 | 0.21% |
| Arrowhead Pharmaceuticals In |
Opened
48,175
|
$1,252,068,000 | 0.20% |
| Compugen Ltd |
3.90%
739,239
|
$1,241,922,000 | 0.20% |
| Kezar Life Sciences Inc |
No change
2,051,676
|
$1,231,006,000 | 0.20% |
| Insmed Inc |
Opened
16,589
|
$1,111,463,000 | 0.18% |
| Aprea Therapeutics, Inc. |
No change
270,000
|
$1,098,900,000 | 0.18% |
| Taiwan Semiconductor Mfg Ltd |
Opened
5,650
|
$982,027,000 | 0.16% |
| Elevation Oncology Inc |
23.26%
330,000
|
$891,000,000 | 0.15% |
| Varonis Sys Inc |
20.00%
16,000
|
$767,520,000 | 0.13% |
| Cartesian Therapeutics Inc |
Opened
25,070
|
$677,141,000 | 0.11% |
| Argenx Se |
Opened
1,556
|
$669,142,000 | 0.11% |
| Lava Therapeutics Nv |
No change
367,582
|
$661,648,000 | 0.11% |
| Prime Medicine Inc |
37.92%
127,424
|
$654,959,000 | 0.11% |
| Cartesian Therapeutics Inc |
Closed
25,071
|
$488,889,000 | |
| Alto Neuroscience Inc |
Closed
30,500
|
$468,175,000 | |
| ICL Group Ltd. |
17.81%
107,238
|
$458,979,000 | 0.07% |
| Camtek Ltd |
97.41%
1,940
|
$242,966,000 | 0.04% |
| Gossamer Bio, Inc. |
78.37%
222,134
|
$200,121,000 | 0.03% |
| Arbe Robotics Ltd |
No change
43,165
|
$82,445,000 | 0.01% |
| Amylyx Pharmaceuticals Inc |
86.51%
36,050
|
$68,495,000 | 0.01% |
| No transactions found | |||
| Showing first 500 out of 122 holdings | |||
Hedge funds similar to Sphera Funds Management Ltd
- Adventist Health System West
- Eam Investors
- Nationale-nederlanden Powszechne Towarzystwo Emerytalne S.A.
- First Turn Management
- Fort Sheridan Advisors
- Exchange Capital Management
- Cornercap Investment Counsel Inc
- Inscription Capital
- Corsair Capital Management, L.P.
- Cynosure
- Divisadero Street Capital Management, L.P.
- 180 Wealth Advisors
- Darwin Global Management
- Naviter Wealth